Publication | Open Access
Multicenter Phase II study of estramustine phosphate plus weekly paclitaxel in patients with androgen‐independent prostate carcinoma
27
Citations
18
References
2004
Year
This regimen of EMP plus weekly paclitaxel was an active and well tolerated treatment for patients with AIPC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1